您的位置: 首页 > 农业专利 > 详情页

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
专利权人:
Boehringer Ingelheim International GmbH
发明人:
Flavio SOLCA,Andree AMELSBERG,Gerd STEHLE,Jacobus C.A. VAN MEEL,Anke BAUM
申请号:
US15828644
公开号:
US20180086744A1
申请日:
2017.12.01
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The invention relates to a therapy of cancer comprising co-administration to a person in need of such treatment and/or co-treatment of a person in need of such treatment with effective amounts of:(1) a compound 1 of formula (I)wherein the groups Ra to Rd have the meanings given in the claims and specification; and(2) at least a further chemotherapeutic agent 2;optionally in combination with radiotherapy, radio-immunotherapy and/or tumour resection by surgery, furthermore, the invention relates to corresponding medicaments and the preparation thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充